Get started
Author

Paula Martínez Vázquez

Observed names: Martínez Vazquez, Paula, P Martinez Vazquez, P Martínez Vazquez, P. Martínez Vazquez, Paula Martinez Vazquez, Paula Martínez Vazquez
ORCID: 0000-0001-5716-0425
Observed ORCID: 0000-0001-5716-0425
OpenAlex ID: A5043263344
Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma
2010 · Mario A. Lorenzetti, Elena De Matteo, et al. · PLoS ONE · 55
PDF
Presence of Human Papilloma Virus in a Series of Breast Carcinoma from Argentina
2013 · Ana Laura Pereira Suarez, Mario Alejandro Lorenzetti, et al. · PLoS ONE · 35
PDF
Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
2020 · Ximena García, Andrés Elía, et al. · Breast Cancer Research and Treatment · 14
Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer
2015 · María May, Julián Mosto, et al. · Experimental and Molecular Pathology · 8
PDF
Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country
2025 · Gabriela Pataccini, Andrés Elia, et al. · Scientific Reports · 4
PDF
FGFR2 ‐ RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression
2024 · María S. Rodriguez, Yamil D. Mahmoud, et al. · International Journal of Cancer · 3
Steroid profile in patients with breast cancer and in mice treated with mifepristone
2023 · Andres Elía, Leo Saldain, et al. · Endocrine Related Cancer · 3
PDF
Abstract OT1-04-02: Mifepristone treatment for breast cancer patients expressing levels of progesterone receptor isoform A (PRA) higher than those of isoform B (PRB)
2018 · M Liguori, C Lanari, et al. · Cancer Research · 3
Abstract PS11-35: Mipra, a window of opportunity study evaluating mifepristone treatment for postmenopausal breast cancer patients with higher levels of progesterone receptor isoform a than b
2021 · Andres Elia, Silvia I Vanzulli, et al. · Cancer Research · 1
Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer
2026 · Virginia Figueroa, Marcela I. Coianis, et al. · British Journal of Cancer
Deciphering the causes of advanced-stage disease at diagnosis among breast cancer patients who attended a suburban hospital in Buenos Aires.
2024 · Marcela I Coianis, Leo Saldain, et al. · PubMed
Abstract 3994: Differential regulation of hormone receptors and Ki67 in luminal breast carcinomas and tumor-adjacent mammary glands by mifepristone treatment
2023 · Leo Saldain, Silvia Vanzulli, et al. · Cancer Research
Abstract 5289: Proteomic profile of breast carcinomas with unbalanced levels of progesterone receptor isoforms
2023 · Andres M. Elia, Jana Sanchez, et al. · Cancer Research
101P Proteome and RNA-Seq changes in breast cancer patients with higher levels of progesterone receptor A than B after mifepristone treatment
2022 · A.M. Elia, J. Sanchez, et al. · Annals of Oncology
55P Morphological changes and regulation of hormone receptor-related proteins in breast cancer patients with higher levels of progesterone receptor A than B treated with mifepristone
2022 · L. Saldain, S. Vanzulli, et al. · Annals of Oncology
Abstract P5-16-09: Transcriptome modulation by mifepristone treatment in breast cancer patients with higher levels of progesterone receptor A than B
2022 · Andres Elia, Martin Abba, et al. · Cancer Research
Abstract P5-05-14: Withdrawn
2019 · AM Elia, P Rojas, et al. · Cancer Research
Abstract P4-09-13: Breast cancer recurrence risk: A role for the progesterone receptor isoforms
2016 · HD Gass, M May, et al. · Cancer Research
Progesterone receptor isoform ratio to define the molecular signature of luminal breast cancers and their antiprogestin responsiveness.
2015 · Maria May, Paola Rojas, et al. · Journal of Clinical Oncology
Nuclear staining of FGFR-2/ STAT-5 and RUNX-2 in mucinous breast cancer: role for FGF pathway
2014 · Maria May, Paola Rojas, et al. · Pathology
Abstract P4-02-18: Antiprogestins as Possible Therapeutic Agents for Breast Cancer Patients Showing a High Expression of the Progesterone Receptor Isoform A
2010 · PA Rojas, G Sequeira, et al. · Cancer Research
Works count: 23
Citation count: 126
H-index: 4
I10-index: 3
Year
Topic
Type